logo
welcome
TechCrunch

TechCrunch

Archon emerges from stealth with $20M and 'antibody cages' to power up drug development | TechCrunch

TechCrunch
Summary
Nutrition label

82% Informative

Archon Biosciences has emerged from stealth with $20 million in seed funding.

The company aims to supercharge antibody treatments using specially designed protein cages that multiply their effects.

This is the first company to be spun out of Baker Lab , the University of Washington research outfit overseen by Nobel Prize winner David Baker .

VR Score

83

Informative language

86

Neutral language

1

Article tone

semi-formal

Language

English

Language complexity

64

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

Affiliate links

no affiliate links